Further mechanistic studies revealed that AA may ameliorate the symptoms of alcoholic hepatitis in mice by inhibiting the phosphorylation of NF-κB-p65 and reducing its expression. This evidence concerns the gene NFKB1 and alcoholic hepatitis.